Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. 2012

Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
Buck Institute for Age Research, Novato, CA 94945, USA.

Oxidative stress and mitochondrial dysfunction have been implicated in the pathology of HD; however, the precise mechanisms by which mutant huntingtin modulates levels of oxidative damage in turn resulting in mitochondrial dysfunction are not known. We hypothesize that mutant huntingtin increases oxidative mtDNA damage leading to mitochondrial dysfunction. We measured nuclear and mitochondrial DNA lesions and mitochondrial bioenergetics in the STHdhQ7 and STHdhQ111 in vitro striatal model of HD. Striatal cells expressing mutant huntingtin show higher basal levels of mitochondrial-generated ROS and mtDNA lesions and a lower spare respiratory capacity. Silencing of APE1, the major mammalian apurinic/apyrimidinic (AP) endonuclease that participates in the base excision repair (BER) pathway, caused further reductions of spare respiratory capacity in the mutant huntingtin-expressing cells. Localization experiments show that APE1 increases in the mitochondria of wild-type Q7 cells but not in the mutant huntingtin Q111 cells after treatment with hydrogen peroxide. Moreover, these results are recapitulated in human HD striata and HD skin fibroblasts that show significant mtDNA damage (increased lesion frequency and mtDNA depletion) and significant decreases in spare respiratory capacity, respectively. These data suggest that mtDNA is a major target of mutant huntingtin-associated oxidative stress and may contribute to subsequent mitochondrial dysfunction and that APE1 (and, by extension, BER) is an important target in the maintenance of mitochondrial function in HD.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004272 DNA, Mitochondrial Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. Mitochondrial DNA,mtDNA
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006816 Huntington Disease A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4) Huntington Chorea,Juvenile Huntington Disease,Akinetic-Rigid Variant of Huntington Disease,Chorea, Chronic Progressive Hereditary (Huntington),Chronic Progressive Hereditary Chorea (Huntington),Huntington Chronic Progressive Hereditary Chorea,Huntington Disease, Akinetic-Rigid Variant,Huntington Disease, Juvenile,Huntington Disease, Juvenile-Onset,Huntington Disease, Late Onset,Huntington's Chorea,Huntington's Disease,Juvenile-Onset Huntington Disease,Late-Onset Huntington Disease,Progressive Chorea, Chronic Hereditary (Huntington),Progressive Chorea, Hereditary, Chronic (Huntington),Akinetic Rigid Variant of Huntington Disease,Chorea, Huntington,Chorea, Huntington's,Huntington Disease, Akinetic Rigid Variant,Huntington Disease, Juvenile Onset,Huntington Disease, Late-Onset,Juvenile Onset Huntington Disease,Late Onset Huntington Disease

Related Publications

Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
September 1999, Neuroscience letters,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
August 2020, DNA and cell biology,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
January 1999, Annals of the New York Academy of Sciences,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
September 2013, Neurobiology of aging,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
September 2013, Free radical biology & medicine,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
January 2021, Critical care (London, England),
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
October 2014, Lupus,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
October 1991, JAMA,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
June 2010, Journal of bioenergetics and biomembranes,
Almas Siddiqui, and Sulay Rivera-Sánchez, and María del R Castro, and Karina Acevedo-Torres, and Anand Rane, and Carlos A Torres-Ramos, and David G Nicholls, and Julie K Andersen, and Sylvette Ayala-Torres
January 2024, microPublication biology,
Copied contents to your clipboard!